LIWANLI Innovation Co., Ltd. operates in the biomedical science industry in Taiwan and internationally. The company offers Vigoway and powder collection products for males, females, the elderly, and children. Its products include black elderberry powder, probiotic enzymes, oral care tablets, resveratrol red grape extract, e-soothing powder, tooth guard tablets, bovine and goat's milk bites, bilberry tablets, drops, and other products. The company was formerly known as Carry Technology International Co., Ltd. and changed its name to LIWANLI Innovation Co., Ltd. in 2015. LIWANLI Innovation Co., Ltd. was founded in 1980 and is headquartered in Taipei, Taiwan.
Frequently asked questions
What sector does LIWANLI Innovation Co Ltd (3054) operate in?
LIWANLI Innovation Co Ltd belongs to the Information Technology sector and operates in the Drug Manufacturers - Specialty & Generic industry.
What is LIWANLI Innovation Co Ltd (3054) current stock price?
As of the latest data, LIWANLI Innovation Co Ltd stock price is NT$48.55, with a previous close of NT$48.55.
What is LIWANLI Innovation Co Ltd (3054) current market capitalization?
LIWANLI Innovation Co Ltd market cap is approximately 3.92 billion.
What is LIWANLI Innovation Co Ltd (3054) Earnings Per Share (EPS)?
The trailing EPS is NT$4.82.
What is LIWANLI Innovation Co Ltd (3054) Price-to-Earnings (P/E) ratio?
LIWANLI Innovation Co Ltd current P/E ratio is 10.07.
What is LIWANLI Innovation Co Ltd (3054) EBITDA?
LIWANLI Innovation Co Ltd EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 132.88 million.
Does LIWANLI Innovation Co Ltd (3054) pay dividends?
No. LIWANLI Innovation Co Ltd does not pay a dividend.
What is LIWANLI Innovation Co Ltd (3054) beta (volatility) score?
LIWANLI Innovation Co Ltd has a beta of -0.504, indicating lower volatility than the overall market.
